Drug Information

Drug General Information
Drug ID
D0G6BG
Former ID
DNC013875
Drug Name
2-Benzylbenzo[f]chromen-3-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Structure
Download
2D MOL

3D MOL
Formula
C20H14O2
Canonical SMILES
C1=CC=C(C=C1)CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O
InChI
1S/C20H14O2/c21-20-16(12-14-6-2-1-3-7-14)13-18-17-9-5-4-8-15(17)10-11-19(18)22-20/h1-11,13H,12H2
InChIKey
OOALWLFUSOVWMV-UHFFFAOYSA-N
PubChem Compound ID
10731937
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530009]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.